Affigen SARL
Antibodies, Elisa and PCR Assays, Recombinant Proteins, Plasmids, Viral Controls, Cell Culture Media, Cell lines.
Tunisia
6 employees
Series A
Total: $17.00M
Biotechnology, Pharmaceutical
General Information
Tunisia
BounceWatch is an independent company data service, not affiliated with Affigen SARL. To contact Affigen SARL, visit affigen.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Affigen SARL compare?
A PDF of Affigen SARL and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Affigen SARL soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Tunisia Market
Biotechnology
About Affigen SARL
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | $17.00M | 1 |
|
21 Feb 2017 |
Affigen SARL Alternatives & Competitors
Contract research organization specializing in custom antibody discovery and development
Helping our customers to clearly see every cell in the flow
FAQ About Affigen SARL
Source: BounceWatch company record for Affigen SARL, https://bouncewatch.com/company/affigen, updated 30 December 2024. When citing, please name BounceWatch and link this page.
